GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Winston Pharmaceuticals Inc (GREY:WPHM) » Definitions » Days Sales Outstanding

Winston Pharmaceuticals (Winston Pharmaceuticals) Days Sales Outstanding : 4.61 (As of Mar. 2010)


View and export this data going back to 2006. Start your Free Trial

What is Winston Pharmaceuticals Days Sales Outstanding?

Winston Pharmaceuticals's average Accounts Receivable for the three months ended in Mar. 2010 was $0.02 Mil. Winston Pharmaceuticals's Revenue for the three months ended in Mar. 2010 was $0.32 Mil. Hence, Winston Pharmaceuticals's Days Sales Outstanding for the three months ended in Mar. 2010 was 4.61.

The historical rank and industry rank for Winston Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

WPHM's Days Sales Outstanding is not ranked *
in the Drug Manufacturers industry.
Industry Median: 71.44
* Ranked among companies with meaningful Days Sales Outstanding only.

Winston Pharmaceuticals's Days Sales Outstanding declined from Mar. 2009 (5.37) to Mar. 2010 (4.61).


Winston Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Winston Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Winston Pharmaceuticals Days Sales Outstanding Chart

Winston Pharmaceuticals Annual Data
Trend Sep05 Sep06 Sep07 Dec08 Dec09
Days Sales Outstanding
- - - 26.99 4.32

Winston Pharmaceuticals Quarterly Data
Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.37 8.88 10.66 6.73 4.61

Competitive Comparison of Winston Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Winston Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Winston Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Winston Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Winston Pharmaceuticals's Days Sales Outstanding falls into.



Winston Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Winston Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2009 is calculated as

Days Sales Outstanding (A: Dec. 2009 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2008 ) + Accounts Receivable (A: Dec. 2009 )) / count ) / Revenue (A: Dec. 2009 )*Days in Period
=( (0.017 + 0.016) / 2 ) / 1.395*365
=0.0165 / 1.395*365
=4.32

Winston Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2010 is calculated as:

Days Sales Outstanding (Q: Mar. 2010 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2009 ) + Accounts Receivable (A: Mar. 2010 )) / count ) / Revenue (A: Mar. 2010 )*Days in Period
=( (0.016 + 0) / 1 ) / 0.317*365 / 4
=0.016 / 0.317*365 / 4
=4.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Winston Pharmaceuticals  (GREY:WPHM) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Winston Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Winston Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Winston Pharmaceuticals (Winston Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
100 North Fairway Drive, Suite 134, Vernon Hills, IL, USA, 60061
Winston Pharmaceuticals Inc is a pharmaceutical company, which is engaged in the discovery and development of products for pain management. The company focuses on major pain indications such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo- and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease.
Executives
Frost Phillip Md Et Al 10 percent owner 4400 BISCAYNE BLVD, MIAMI FL 33137-3227
Frost Gamma Investments Trust 10 percent owner 4400 BISCAYNE BLVD, MIAMI FL 33137
Subbarao V Uppaluri director 4400 BISCAYNE BOULEVARD, SUITE 1500, MIAMI FL 33137
Curtis Lockshin director 4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Glenn L Halpryn director 4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Steven Jerry Glauser 10 percent owner 1428 BRICKELL AVENUE, SUITE 105, MIAMI FL 33131
Noah M Silver director, officer: Vice President 4400 BISCAYNE BOULEVARD, SUITE 950, MIAMI FL 33137
Alan Jay Weisberg director, officer: Chief Financial Officer 2500 NORTH MILITARY TRAIL, SUITE 206, BOCA RATON FL 33431
Stephen Bittel 10 percent owner 4400 BISCAYNE BOULEVARD SUITE 950 MIAMI FL 33137

Winston Pharmaceuticals (Winston Pharmaceuticals) Headlines

No Headlines